Mesothelioma Applied Research Foundation Associated With Direct Exposure to Asbestos
Mesothelioma applied research foundation – Diffuse malignant pleural mesothelioma is an aggressive cancer with poor prognosis, which has been recently associated with direct exposure to mesotheolima asbestos. As a consequence of this new knowledge, it is predicted to have its highest incidence around the years 2021-2021. This malignancy accounts for approximately fifteen percent of all malignancies in the developed countries. The malignancy usually manifests slowly over a period of 2 to 5 years.
It has been found that most people exposed to a high amount of asbestos are at higher risk of developing this disease. It has also been observed that the rate of diagnosis of this disease is very high in developed countries, in contrast to less developed countries. This is the main thing in the treatment to be followed up and accompanied by Mesothelioma applied research foundation.
Why Mesothelioma Applied Research Foundation Works For You
Diffuse cancer of the mesothelium (DAMM) occurs when abnormal cancerous cells are allowed to settle in a smooth region close to the surface of the mesothelium without interrupting the adjacent healthy tissues. These abnormal cells form into a cluster and may generate fibrous mass that provides a perfect platform for infection to take place.
The most common symptoms of diffuse malignant mesothelioma are pain in the chest, shortness of breath, nausea and fatigue. It is very important to determine the presence of any of these symptoms at an early stage. This will facilitate the proper treatment that is necessary to control the growth of tumor. The treatments used for diffuse malignant mesothelioma vary according to the stage the cancer is in.
Treatment For Malignant Pleural Mesothelioma
A few years back, Thoracic Allografts (TA), a surgical procedure used for the correction of spinal deformities was discovered to be effective in the treatment of diffuse malignant pleural mesothelioma. During this procedure, doctors remove problem tissue near the lungs or the heart and reattach it to the affected tissue with the use of flexible metal wires.
The recovery period is longer and certain cases may need more than one surgery. In fact, Thoracic Allografts can sometimes be performed two to three times in a single session.
Another alternative in the treatment of this deadly disease is the Tumor Supportive Therapy (TST). This procedure is accomplished through the means of injecting the patient’s own body-building protein, known as albumin, into the affected areas.
However, this approach has been found out to be less effective in some patients. Furthermore, it has also been observed that there is a high relapse rate of those who underwent this procedure. Some specialists also believe that the lack of certain essential proteins, such as Albumin and C-reactive proteins, may contribute to the severity of symptoms in patients undergoing this treatment.
Alternative Medicines Malignant Pleural Mesothelioma
Several alternative medicines have also been used in the treatment of this disease, including Ginkgo biloba, ayurvedic herbs, and the combination of these herbs and other herbal medications. In chemotherapy, cisplatin, carboplatin, bleomycin, and combination chemotherapy have been administered to some patients.
It is important to note that different response rates are observed between these different chemotherapy drugs. Response rates in the case of Ginkgo biloba are usually higher compared to that of oxalate and methotrexate. In addition, cisplatin has been found out to be ineffective in improving survival in malignant mesothelioma patients. This medicine usually produces minimal effects on the spread of this disease.
Radiation therapy and chemical pacemakers are likewise used in the treatment of diffuse malignant pleural mesothelioma. These treatments are used to eliminate or reduce the tumor growth in a targeted area. The areas may be selected depending on the tumor cell density. However, the survival rate of patients is usually quite low in this case.
Peritoneal Mesothelioma – Characteristic of Malignant Pleural Mesothelioma
Peritoneal mesothelioma is often referred to as diffuse malignant pleural mesothelioma, because its main features are the presence of a widespread chest wall pain, emaciation, and cough. Peritoneal tumor may not produce any symptoms.
Ultrasonographic assessment and chest wall ultrasound are the only means of obtaining additional information regarding this disease. Peritoneal mesothelioma staging system can be used in order to assess the tumor in a particular chest wall cavity.
Chemotherapy is usually administered after the completion of Extra pleural Mesothelioma staging system. This treatment includes the use of an anti-cancer drug (cilastrene), a drug combination referred to as cisplatin, and one or more additional drugs.
A chest X-ray is usually done at the end of the process in order to evaluate the effectiveness of the medicines taken. However, if the disease has spread beyond the peritoneal cavity, extra pleural pneumonectomy and brachytherapy are also required.